Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Open-label Long Term Extension Study to Assess the Safety of TB006 in Patients Who Have Completed Protocol TB006AD2102 and in De Novo Patients With Alzheimer's Disease

NCT05476783 is registered in ClinicalTrials.gov with TrueBinding, Inc. as lead sponsor.

NCT NCT05476783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Open-label Long Term Extension Study to Assess the Safety of TB006 in Patients Who Have Completed Protocol TB006AD2102 and in De Novo Patients With Alzheimer's Disease
Lead sponsor
TrueBinding, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 15, 2022
Completion date
November 17, 2023
Enrollment
119 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease